Showing results 6 to 13 of 13
< previous
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
2001 | 111 | |||
Predicting HBsAg clearance responses during ARC-520 RNA interference (RNAi) therapy based on HBsAg epitope profile analysis Proceeding/Conference:Journal of Hepatology | 2016 | 39 | ||
2017 | ||||
2020 | 20 | |||
RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg Journal:Science Translational Medicine | 2017 | 32 | ||
Safety, Tolerability, and Pharmacokinetics of ARC-520 Injection, an RNA Interference-Based Therapeutic for the Treatment of Chronic Hepatitis B Virus Infection, in Healthy Volunteers Journal:Clinical Pharmacology in Drug Development | 2017 | 51 | ||
Synthetic RNAi triggers and their use in chronic hepatitis B therapies with curative intent Journal:Antiviral Research | 2015 | |||
World Gastroenterology Organisation Global Guideline Hepatitis B Journal:Journal of Clinical Gastroenterology | 2016 | 52 |